Supernus Pharmaceuticals SUPN Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's payments to acquire property, plant, and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's payments to acquire property, plant, and equipment?
- Supernus Pharmaceuticals (SUPN) reported payments to acquire property, plant, and equipment of $0 in Q1 2026.
- How has Supernus Pharmaceuticals's payments to acquire property, plant, and equipment changed year-over-year?
- Supernus Pharmaceuticals's payments to acquire property, plant, and equipment decreased by 100.0% year-over-year, from $327K to $0.
- What is the long-term trend for Supernus Pharmaceuticals's payments to acquire property, plant, and equipment?
- Over 2 years (2023 to 2025), Supernus Pharmaceuticals's payments to acquire property, plant, and equipment has grown at a 51.0% compound annual growth rate (CAGR), from $587K to $1.34M.